Terns Pharmaceuticals, Inc.
NASDAQ: TERN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amy L. Burroughs
- Employees
- 59
- Headquarters
- Foster City, United States
- IPO year
- 2021
- Market cap
- $4.8B
- Website
- https://www.ternspharma.com
Loading TERN…
Loading profile data…Frequently asked questions about TERN
What does Terns Pharmaceuticals, Inc. (TERN) do?
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key...
Where does TERN trade?
Terns Pharmaceuticals, Inc. (TERN) trades on the NASDAQ Global Select.
What sector is TERN in?
Terns Pharmaceuticals, Inc. (TERN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Terns Pharmaceuticals, Inc.?
Amy L. Burroughs is the chief executive officer of Terns Pharmaceuticals, Inc. (TERN).
Where is Terns Pharmaceuticals, Inc. headquartered?
Terns Pharmaceuticals, Inc. is headquartered in United States.
Does TERN pay a dividend?
Terns Pharmaceuticals, Inc. (TERN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TERN go public?
Terns Pharmaceuticals, Inc. (TERN) completed its initial public offering in 2021.